TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm June 9, 1989
